P
Paul Pracy
Researcher at Queen Elizabeth Hospital Birmingham
Publications - 29
Citations - 617
Paul Pracy is an academic researcher from Queen Elizabeth Hospital Birmingham. The author has contributed to research in topics: Medicine & Referral. The author has an hindex of 15, co-authored 26 publications receiving 439 citations. Previous affiliations of Paul Pracy include University Hospitals Birmingham NHS Foundation Trust.
Papers
More filters
Journal ArticleDOI
Follow-up after treatment for head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
TL;DR: This paper provides recommendations on the work up and management of lateral skull base cancer based on the existing evidence base for this rare condition by reviewing the existing literature and collating experience from varying practices across the UK.
Journal ArticleDOI
Safety and 30-day outcomes of tracheostomy for COVID-19: a prospective observational cohort study
Omar Breik,Paul Nankivell,Paul Nankivell,Neil Sharma,Neil Sharma,Mansoor N Bangash,Camilla Dawson,Matthew Idle,Peter Isherwood,Christopher Jennings,Damian Keene,Mav Manji,T. Martin,Rob Moss,Nick Murphy,Dhruv Parekh,Sat Parmar,Jaimin Patel,Paul Pracy,Prav Praveen,Carla Richardson,Alex G. Richter,Rajneesh Sachdeva,Adrian M Shields,Somiah Siddiq,Simon Smart,Laura Tasker +26 more
TL;DR: Independent of the severity of critical illness from COVID-19, 30-day survival was higher and ICU stay shorter in patients receiving tracheostomy, and early trachostomy appears to be safe in CO VID-19.
Journal ArticleDOI
Dysphagia presentation and management following COVID-19: an acute care tertiary centre experience.
Camilla Dawson,R Capewell,S H Ellis,S Matthews,S Adamson,M Wood,L Fitch,K Reid,Martin Shaw,J Wheeler,Paul Pracy,Paul Nankivell,Neil Sharma +12 more
TL;DR: The crucial role of intensive swallow rehabilitation to manage dysphagia associated with Covid-19, including therapeutic respiratory weaning for those with a tracheostomy, is described.
Journal ArticleDOI
Hypopharyngeal cancer: United Kingdom National Multidisciplinary Guidelines.
TL;DR: The evidence base pertaining to the management of hypopharyngeal cancer is discussed, recommendations on management for this group of patients receiving cancer care are provided and full and unbiased discussion of treatment options should take place to allow informed patient choice.
Journal ArticleDOI
Hypofractionated accelerated radiotherapy with concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck.
Anthony K. C. Chan,Paul Sanghera,B. A. Choo,Christopher C. McConkey,Hisham Mehanna,S. Parmar,Paul Pracy,J. Glaholm,Andrew Hartley +8 more
TL;DR: Hypofractionated accelerated radiotherapy with concurrent carboplatin achieves a high local control and should be considered for a radiotherapy dose-escalation study using intensity-modulated radiotherapy.